Debra Zack
Plus aucun poste en cours
Fortune : 174 135 $ au 31/03/2024
Profil
Debra Jeske Zack worked as an Executive Director-Global Product Area at Amgen, Inc. and as a Vice President-Clinical Development at Xencor, Inc. Prior to that, she was an Associate Professor at the University of California, Los Angeles.
She also served as the Chief Medical Officer at Exagen, Inc. from 2020 to 2022.
Dr. Zack received her undergraduate degree from Texas Christian University and her doctorate from The University of Texas Southwestern Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EXAGEN, INC.
0,64% | 18/04/2023 | 109 519 ( 0,64% ) | 174 135 $ | 31/03/2024 |
Anciens postes connus de Debra Zack
| Sociétés | Poste | Fin |
|---|---|---|
| EXAGEN INC. | Chief Tech/Sci/R&D Officer | 05/12/2022 |
| University of California, Los Angeles | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
| XENCOR, INC. | Corporate Officer/Principal | - |
Formation de Debra Zack
| Texas Christian University | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| EXAGEN INC. | Health Services |
